Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Night of Sciences' at X-FAB Erfurt | Manfred Riemer, CEO, X Fab Silicon Foundries EVXFAB:PAR
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Manfred Riemer is the CEO of this renowned company
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
The Journey Behind Allbirds' Wool Runner: From Prototype to Global Phenomenon | Tim Brown, Co-Founder, Allbirds Inc.
00:10:00
The Founder Of This $10 Billion Israeli Startup Called Wiz Is Shaking Up Cloud Security | Assaf Rappaport, CEO, WIZ Corp Inc3862K:KOE
00:10:00
Adapting to Higher Energy Prices: Antoine Lesne of State Street Global Advisors Discusses Inflation, ECB Insights, and Investor Positioning in European and ETF Markets
00:10:00
Managing Fixed Income Investments: A Conversation with Dana Emery | Dana Emery, CEO , Dodge & Cox.
00:10:00
Jim Greig: Representative of Metals Group Inc. | Jim Greig, CEO of Metals Group Inc.
00:10:00
Josh Green on Mastering Online Reputation and Digital Strategies: From Tech Beginnings to CEO
00:10:00
Onyx Gold's Exploration Strategy and Upcoming Drilling Projects
00:10:00
To Buy or Rent: Making the Right Housing Decision | Financial Design Studio
00:10:00
How Netcall's Liberty Platform Empowers UK Councils with Low-Code Innovation | James Ormondroyd , CEO at netcall plc
00:10:00
Executive Chairman Justyn Peters Discusses Project Progress and Market Challenges | Daniel Justyn Douglas Peters, Chairman, Neurizer Ltd.
00:10:00
"Up to seven wells" are promised by Chariot's CFO during the following 18 months. | ADONIS POUROULIS, CEO, Chariot LtdOIGLF:PKC
00:10:00
Philippe Guillemot, CEO of Vallourec, Reflects on 2023 Achievements and Looks Ahead to 2024 | Philippe Guillemot, CEO, Vallourec SA.